SECTION 05 : FINANCIAL STATEMENTS & OTHERS 80 Directors’ Report (Cont’d) Registration No: 2 199201005296 (236800 - T) ISSUE OF SHARES AND DEBENTURES During the financial year, the Company increased its issued and paid-up share capital from RM163,513,933 to RM173,513,933 by way of issuance of 10,000,000 new ordinary shares pursuant to the exercise of Warrants 2020/2025 at an exercise price of RM1.00 per ordinary share. The new ordinary shares issued during the financial year rank pari passu in all respects with the existing ordinary shares of the Company. There were no other issues of shares during the financial year. The Company did not issue any debentures during the financial year. TREASURY SHARES As at 31 March 2026, the Company held 1,289,400 treasury shares at a total cost of RM1,199,000. WARRANTS 2020/2025 On 7 January 2021, the Company listed and quoted 44,971,973 Warrants pursuant to the Issuance of Free Warrants on the basis of one (1) Warrant for every three (3) existing shares held in the Company. During the financial year, a total of 10,000,000 Warrants were exercised by the Warrant Holders, resulting in the issuance of 10,000,000 new ordinary shares in the Company. Upon the expiry of the exercise period of the Warrants on 26 December 2025, the remaining 24,971,973 Warrants that had not been exercised lapsed and ceased to be valid for any further exercise. Consequently, the Warrants were delisted from the Official List of Bursa Malaysia Securities Berhad on 29 December 2025. EMPLOYEES’ SHARES SCHEME (“ESS”) In the Extraordinary General Meeting on 9 February 2018, the Shareholders have approved the ESS comprising Employees' Option Scheme ("ESOS") and Employees' Share Grant ("ESG") that came into effect on 12 February 2018 for a period of 5 years up to 12 February 2023. Subsequently, the Company has extended the duration of the ESS for another 5 years to 12 February 2028. On 1 June 2022, the Company made an offer of 6,100,000 ESOS Option under the ESS ("1st Award") to the eligible Directors and employees of the Company and its subsidiaries (collectively as “Eligible Persons”). The ESOS Option was offered in 2 tranches with the 1st tranche of 40% comprising 2,440,000 ESOS Option with no vesting period and the 2nd tranche of 60% comprising 3,660,000 ESOS Option with a vesting period of 1 year till 31 May 2023. The Company had subsequently on 2 January 2024 made an offer of 11,900,000 new ESOS Option (“2nd Award”) for an option period of three (3) years commencing from 2 January 2024 and expiring on 1 January 2027 to the Eligible Persons. The 1st Award of ESOS Option expired on 31 May 2024. The total number of outstanding ESOS Options granted under the ESS as at the financial year end is 10,300,000.
RkJQdWJsaXNoZXIy NDgzMzc=